Literature DB >> 30374978

Sizable Scaffold-Free Tissue-Engineered Articular Cartilage Construct for Cartilage Defect Repair.

In-Su Park1, Ri Long Jin2, Hyun Ju Oh3, Minh-Dung Truong1, Byung Hyune Choi4, Sang-Hyug Park5, Do Young Park1,2, Byoung-Hyun Min1,2,3.   

Abstract

This study introduces an implantable scaffold-free cartilage tissue construct (SF) that is composed of chondrocytes and their self-produced extracellular matrix (ECM). Chondrocytes were grown in vitro for up to 5 weeks and subjected to various assays at different time points (1, 7, 21, and 35 days). For in vivo implantation, full-thickness defects (n = 5) were manually created on the trochlear groove of the both knees of rabbits (16-week old) and 3 week-cultured SF construct was implanted as an allograft for a month. The left knee defects were implanted with 1, 7, and 21 days in vitro cultured scaffold-free engineered cartilages. (group 2, 3, and 4, respectively). The maturity of the engineered cartilages was evaluated by histological, chemical and mechanical assays. The repair of damaged cartilages was also evaluated by gross images and histological observations at 4, 8, and 12 weeks postsurgery. Although defect of groups 1, 2, and 3 were repaired with fibrocartilage tissues, group 4 (21 days) showed hyaline cartilage in the histological observation. In particular, mature matrix and columnar organization of chondrocytes and highly expressed type II collagen were observed only in 21 days in vitro cultured SF cartilage (group 4) at 12 weeks. As a conclusion, cartilage repair with maturation was recapitulated when implanted the 21 day in vitro cultured scaffold-free engineered cartilage. When implanting tissue-engineered cartilage, the maturity of the cartilage tissue along with the cultivation period can affect the cartilage repair.
© 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  3D cell culture; Articular cartilage; Cartilage repair; Chondrocytes; Scaffold-free; Tissue engineering

Mesh:

Year:  2018        PMID: 30374978     DOI: 10.1111/aor.13329

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  6 in total

Review 1.  Progress and prospect of technical and regulatory challenges on tissue-engineered cartilage as therapeutic combination product.

Authors:  Xiaolei Guo; Yuan Ma; Yue Min; Jiayi Sun; Xinli Shi; Guobiao Gao; Lei Sun; Jiadao Wang
Journal:  Bioact Mater       Date:  2022-06-27

2.  Human integrin α10β1-selected mesenchymal stem cells home to cartilage defects in the rabbit knee and assume a chondrocyte-like phenotype.

Authors:  Camilla Andersen; Kristina Uvebrant; Yuki Mori; Stacie Aarsvold; Stine Jacobsen; Lise Charlotte Berg; Evy Lundgren-Åkerlund; Casper Lindegaard
Journal:  Stem Cell Res Ther       Date:  2022-05-16       Impact factor: 8.079

3.  Biodegradable Poly(D-L-lactide-co-glycolide) (PLGA)-Infiltrated Bioactive Glass (CAR12N) Scaffolds Maintain Mesenchymal Stem Cell Chondrogenesis for Cartilage Tissue Engineering.

Authors:  Clemens Gögele; Silvana Müller; Svetlana Belov; Andreas Pradel; Sven Wiltzsch; Armin Lenhart; Markus Hornfeck; Vera Kerling; Achim Rübling; Hannes Kühl; Kerstin Schäfer-Eckart; Bernd Minnich; Thomas Martin Weiger; Gundula Schulze-Tanzil
Journal:  Cells       Date:  2022-05-07       Impact factor: 7.666

4.  Hyaluronic acid hydrogel encapsulated BMP-14-modified ADSCs accelerate cartilage defect repair in rabbits.

Authors:  Hao Liu; Yongjun Rui; Jun Liu; Fandong Gao; Yesheng Jin
Journal:  J Orthop Surg Res       Date:  2021-11-03       Impact factor: 2.359

5.  SETD7 regulates chondrocyte differentiation and glycolysis via the Hippo signaling pathway and HIF‑1α.

Authors:  Maoquan Li; Jinqiu Ning; Jiwei Wang; Qiqian Yan; Ke Zhao; Xiaoshi Jia
Journal:  Int J Mol Med       Date:  2021-10-07       Impact factor: 4.101

Review 6.  New Insights into Cartilage Tissue Engineering: Improvement of Tissue-Scaffold Integration to Enhance Cartilage Regeneration.

Authors:  Sahar Jelodari; Amin Ebrahimi Sadrabadi; Fatemeh Zarei; Shahrbanoo Jahangir; Mahmoud Azami; Mohsen Sheykhhasan; Samaneh Hosseini
Journal:  Biomed Res Int       Date:  2022-01-25       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.